Haemonetics Corporation
Status: Publicly traded
Direct answer
Haemonetics Corporation is publicly traded on NYSE under the ticker HAE.
Haemonetics Corporation is a healthcare enterprise dedicated to providing medical products and comprehensive solutions, structured into three main business areas: Plasma, Blood Center, and Hospital. In its Plasma segment, the company develops automated plasma collection systems, exemplified by the NexSys PCS and PCS2 devices, along with necessary disposables and intravenous solutions. It also offers integrated...
Can you invest in Haemonetics Corporation?
Yes. Haemonetics Corporation trades publicly on NYSE as HAE.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Haemonetics Corporation
Detailed equity research is provided by MarketSnap.